» Articles » PMID: 35822018

Patho-Physiology of Aging and Immune-Senescence: Possible Correlates With Comorbidity and Mortality in Middle-Aged and Old COVID-19 Patients

Overview
Journal Front Aging
Specialty Geriatrics
Date 2022 Jul 13
PMID 35822018
Authors
Affiliations
Soon will be listed here.
Abstract

During the last 2 years, the entire world has been severely devastated by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic (COVID-19) as it resulted in several million deaths across the globe. While the virus infects people indiscriminately, the casualty risk is higher mainly in old, and middle-aged COVID-19 patients. The incidences of COVID-19 associated co-morbidity and mortality have a great deal of correlation with the weakened and malfunctioning immune systems of elderly people. Presumably, due to the physiological changes associated with aging and because of possible comorbidities such as diabetes, hypertension, obesity, cardiovascular, and lung diseases, which are more common in elderly people, may be considered as the reason making the elderly vulnerable to the infection on one hand, and COVID-19 associated complications on the other. The accretion of senescent immune cells not only contributes to the deterioration of host defense, but also results in elevated inflammatory phenotype persuaded immune dysfunction. In the present review, we envisage to correlate functioning of the immune defense of older COVID-19 patients with secondary/super infection, increased susceptibility or aggravation against already existing cancer, infectious, autoimmune, and other chronic inflammatory diseases. Moreover, we have discussed how age-linked modulations in the immune system affect therapeutic response against administered drugs as well as immunological response to various prophylactic measures including vaccination in the elderly host. The present review also provides an insight into the intricate pathophysiology of the aging and the overall immune response of the host to SARS-CoV-2 infection. A better understanding of age-related immune dysfunction is likely to help us in the development of targeted preemptive strategies for deadly COVID-19 in elderly patients.

Citing Articles

Changes in the innate immune response to SARS-CoV-2 with advancing age in humans.

Agrawal S, Tran M, Jennings T, Soliman M, Heo S, Sasson B Immun Ageing. 2024; 21(1):21.

PMID: 38515147 PMC: 10956333. DOI: 10.1186/s12979-024-00426-3.


NLRP3 Inflammasome's Activation in Acute and Chronic Brain Diseases-An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes.

Chiarini A, Gui L, Viviani C, Armato U, Dal Pra I Biomedicines. 2023; 11(4).

PMID: 37189617 PMC: 10135565. DOI: 10.3390/biomedicines11040999.


Potential of Nano-Antioxidants and Nanomedicine for Recovery from Neurological Disorders Linked to Long COVID Syndrome.

Akanchise T, Angelova A Antioxidants (Basel). 2023; 12(2).

PMID: 36829952 PMC: 9952277. DOI: 10.3390/antiox12020393.


Older age and depressive state are risk factors for re-positivity with SARS-CoV-2 Omicron variant.

Li M, Peng H, Duan G, Wang J, Yu Z, Zhang Z Front Public Health. 2022; 10:1014470.

PMID: 36268004 PMC: 9576942. DOI: 10.3389/fpubh.2022.1014470.


SARS-CoV-2, long COVID, prion disease and neurodegeneration.

Zhao Y, Jaber V, Lukiw W Front Neurosci. 2022; 16:1002770.

PMID: 36238082 PMC: 9551214. DOI: 10.3389/fnins.2022.1002770.

References
1.
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q . Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020; 94:91-95. PMC: 7194638. DOI: 10.1016/j.ijid.2020.03.017. View

2.
Al-Benna S . Association of high level gene expression of ACE2 in adipose tissue with mortality of COVID-19 infection in obese patients. Obes Med. 2020; 19:100283. PMC: 7368415. DOI: 10.1016/j.obmed.2020.100283. View

3.
Sapey E, Greenwood H, Walton G, Mann E, Love A, Aaronson N . Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence. Blood. 2013; 123(2):239-48. PMC: 3888290. DOI: 10.1182/blood-2013-08-519520. View

4.
Frasca D, Blomberg B, Paganelli R . Aging, Obesity, and Inflammatory Age-Related Diseases. Front Immunol. 2017; 8:1745. PMC: 5725402. DOI: 10.3389/fimmu.2017.01745. View

5.
Iacobellis G, Malavazos A, Ferreira T . COVID-19 Rise in Younger Adults with Obesity: Visceral Adiposity Can Predict the Risk. Obesity (Silver Spring). 2020; 28(10):1795. PMC: 7361935. DOI: 10.1002/oby.22951. View